Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 19 to 79

Combining PRP with fat and bone marrow for treating osteoarthritis

Official title: A Phase II, Randomized, Parallel-Group Study to Investigate the Combined Use of PRP with Lipoaspirate And/or Bone Marrow Aspirate in Osteoarthritis

Run by Pagdin Health · NCT03984461 · Data updated 2026-11-12

This study is testing whether combining platelet-rich plasma with fat or bone marrow can help people with osteoarthritis feel better in their major joints.

Quick facts

PhasePhase 2
Study typeInterventional
Ages19 Years to 79 Years
SexAll
Enrollment240 (estimated)
SponsorPagdin Health
Academic / other
Locations1 site (Kelowna, British Columbia)
StatusRecruiting
StartedSeptember 1, 2020
Main results expectedDecember 2027
Study endsDecember 2027
Registry record updatedNovember 15, 2024
Trial IDNCT03984461 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 19 and older with evidence of osteoarthritis in a major joint and Kellgren & Lawrence Grades 1-3.

Probably not a fit

Patients with severe osteoarthritis (Grade 4), high BMI, or recent joint surgeries may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the effectiveness of combining platelet-rich plasma (PRP) with lipoaspirate and/or bone marrow aspirate in treating osteoarthritis in major joints. A total of 240 participants will be randomly assigned to one of three treatment groups: one receiving PRP plus lipoaspirate, another receiving PRP plus bone marrow aspirate, and the last group receiving all three treatments together. The outcomes of these combinations will be compared to determine the most effective approach for alleviating symptoms of osteoarthritis.

Why it matters

Potential benefit: If successful, this treatment could significantly improve joint function and reduce pain for patients suffering from osteoarthritis.

How similar studies have gone: Other studies have shown promising results with similar combinations of biologic therapies for osteoarthritis, indicating potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Capable of providing written informed consent and willing and able to adhere to all protocol requirements.
2. Male or female at least 19 years of age at the time of providing written informed consent.
3. Evidence of OsteoArthritis in a major joint requires recent (within one year) imaging, either by x-ray or MRI. Kellgren \& Lawrence Grades 1-3 are accepted for participation.

Exclusion Criteria:

1. BMI \> 35
2. Arthroscopic surgery to the treatment joint within 12 months
3. Cortisone or HA injection within the last 3 months prior to stem cell injection
4. Inability to hold antiplatelet therapy according to treating provider prior to procedure
5. Kellgren \& Lawrence Grade 4 Osteoarthritis
6. Participants with a platelet count less than 100 x 109
7. Participants with a Hemoglobin less than 100 g/L
8. Participants who have an active Infection with fever and/or elevated white blood cell (WBC) count
9. Participants with an active Cancer diagnosis.
10. Participants with autoimmune disorders including rheumatoid arthritis and lupus.
11. Women who are pregnant will be excluded due to the possibility of fetal harm associated with x-rays. Should a participant become pregnant during the study, she will be withdrawn from further treatment and imaging, but can participate in symptom follow-up. Female participants of childbearing potential will be counseled at screening about contraception and encouraged to use birth control for the duration of the study.
12. Participants with allergies to lidocaine, heparin, or epinephrine.

Where it's running

  • Pagdin Health
    Kelowna, British Columbia, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.